Table 2.
Patient cohorts | Dependent variable | Steps in logistic regression | Logistic regression & BIC |
Actual outcome |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
B value | Significance per step | −2ln likely hood | BIC | N | Favourable | Adverse | Total | %NPV,% PPV &%PA | |||
1: Predicting severe CP n = 160 excluding 17 dead 1 survivor not scanned - |
n = 9 All MRI, clinical and biochemic. variables |
0:constant | −7.710 | 160 | 148 | 1 | 149 | 99%NPV | |||
1:WMxBGT | 1.334 | 0.002 | 14.615 | 29.841 | 3 | 8 | 11 | 73%PPV | |||
151 | 9 | 160 | |||||||||
98%Sp | 89% Se | 98% PA | |||||||||
n = 9 All MRI, except WMxBGT, and clinical and biochemical variables |
0:constant | −10.270 | 160 | 149 | 3 | 152 | 98%NPV | ||||
1:TIS | 1.457 | 0.002 | 23.147 | 38.371 | 2 | 6 | 8 | 75%PPV | |||
2:startact cool | −0.446 | 0.05 | 18.690 | 38.990 | 151 | 9 | 160 | ||||
98% Sp | 67% Se | 97% PA | |||||||||
n = 9 Clinical and biochemical variables only |
0:constant | −12.441 | 0.000 | 160 | 149 | 4 | 158 | 94%NPV | |||
1: #anticonv | 1.138 | 0.000 | 53.123 | 68.348 | 2 | 5 | 7 | 71%PPV | |||
2: aEEG | 2.077 | 0.001 | 31.916 | 52.217 | 151 | 9 | 168 | ||||
99% Sp | 56% Se | 96% PA | |||||||||
2: Predicting all CP n = 160 excluding 17 dead and 1 survivor not scanned |
n = 22 All MRI, clinical and biochem. variables |
0:constant | −3.300 | 0.000 | 160 | 135 | 10 | 145 | 93%NPV | ||
1:WMxBGT | 0.915 | 0.000 | 70.255 | 85.480 | 3 | 12 | 15 | 80%PPV | |||
138 | 22 | 160 | |||||||||
98% Sp | 55% Se | 92% PA | |||||||||
n = 22 All MRI, except WMxBGT, and clinical and biochemical variables |
0:constant | −5.755 | 0.000 | 160 | 134 | 10 | 144 | 93%NPV | |||
1: TIS | 0.913 | 0.000 | 60.288 | 75.514 | 4 | 12 | 16 | 75%PPV | |||
138 | 22 | 160 | |||||||||
97% Sp | 55% Se | 91% | |||||||||
n = 22 Clinical and biochemical variables only |
0:constant | −6.439 | 0.000 | 160 | 135 | 14 | 149 | 91%NPV | |||
1: #anticonv | 0.789 | 0.000 | 103.287 | 118.513 | 3 | 8 | 11 | 73% PPV | |||
2:aEEG | 1.081 | 0.001 | 87.437 | 107.738 | 138 | 22 | 160 | ||||
98% Sp | 36% Se | 89% PA |